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Abstract
Purpose We compared visual and refractive
outcomes after implantation of Visian toric
implantable collamer lenses (toric ICLs) and
iris-fixated toric pIOLs (toric Artisans).
Patients and methods A comparative
retrospective analysis was performed. Toric
ICLs were implanted into 30 eyes of 18 patients,
and toric Artisans into 31 eyes of 22 recipients.
We measured the logarithms of the minimum
angle of resolution of uncorrected visual acuity
(logMAR UCVA), logMAR of best spectacle-
corrected corrected VA (logMAR BSCVA), MR,
SE, and astigmatism (by the power vector
method) before surgery and 1, 3, and 6 months
thereafter. Differences between patients
receiving each type of lens were compared by
using a mixed model of repeated measures.
Results Visual improvements were evident
after operation in both groups. By comparing
the attempted to the achieved SE values, we
were able to confirm that correction of
refractive error was similar in both groups.
However, the logMAR UCVAwas significantly
higher in the toric ICL group at all
postoperative time points. Although manifest
cylinder power and astigmatism (calculated by
using the power vector method) gradually
decreased in the toric ICL group, cylinder
power 1 month postoperatively increased from
2.62 to 2.75 D; astigmatism was also
increased at this time in the toric Artisan group.
Conclusion The two tested toric pIOLs were
similar in terms of the ability to correct
refractive error, as assessed 3 months
postoperatively. However toric ICLs corrected
astigmatism more rapidly and safely. Notably,
the large difference in astigmatism level
between the two groups 1 month
postoperatively indicates that toric ICLs are
more effective when used to correct
astigmatism.
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Introduction
Surgical methods correcting astigmatism,
including astigmatic keratectomy,1,2 limbal-
relaxing incision,3 and excimer laser ablation,
assist patients with moderate myopic or
hyperopic astigmatism.4 However,
postoperative regression can occur, some
procedures lack predictability and reliability,
and outcomes may vary according to the
experience of the surgeon and the wound-
healing parameters.5
The toric phakic intraocular lens (pIOL) has
been introduced recently for management of
astigmatism. Toric pIOL implant patients do not
suffer from the disadvantages associated with
corneal refractive surgery, and ametropia
combined with astigmatism can be successfully
corrected.6–11 Several types of pIOLs, including
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angle-supported pIOLs, iris-fixated pIOLs, and posterior
chamber pIOLs, are available. Recently, the latter two
types of pIOLs have become increasingly popular.
The iris-fixated phakic intraocular lens (Artisan Lens;
Ophtec BV, Groningen, the Netherlands) and the Visian
implantable collamer lens (ICL; STAAR Surgical,
Monrovia, CA, USA) have both been approved by the US
Food and Drug Administration (FDA) for treatment of
moderate-to-severe myopia. Recently, a toric iris-fixated
lens and the Visian toric implantable collamer lens have
been modified for use in the correction of spherical and
astigmatic refractive errors.
No previous study has compared the efficacy and
safety of toric pIOLs used to correct myopia with
astigmatism. In the present work, we compared surgical
outcomes in patients receiving iris-fixated toric pIOLs
and Visian toric implantable collamer lenses to treat
astigmatic myopia.
Patients and methods
We reviewed the medical records of 61 eyes of 40 patients
who underwent toric pIOL implantation in our
Department between May 2005 and March 2009. This
comparative and retrospective study was approved by
our Institutional Review Board. All procedures were
performed by two surgeons (T-I Kim and EK Kim). Both
had at least 5 years of experience with implantation of
both types of pIOLs. All patients were fully briefed on
the risks and details of the surgical methods employed,
and provided written informed consent in accordance
with the Declaration of Helsinki.
All patients were aged at least 21 years, were in good
general health, had demonstrated stable refraction for at
least 1 year, had astigmatism equal to or greater than 1.5
D, showed no ocular pathology, had endothelial cell
counts of more than 2000 cells/mm2, showed an anterior
chamber depth (ACD) of more than 3.0 mm, had a
mesopic pupil size equal to or less than 6.0 mm, and did
not have a convex iris configuration. Exclusion criteria
were anisometropia; anterior segment pathology;
presence of abnormal endothelial cells, a shallow ACD,
or an abnormal iris or pupil configuration; inadequate
eyelid closure; cataracts; recurrent or chronic uveitis; a
history of prior corneal or intraocular surgery; glaucoma;
any fundus abnormality; retinal detachment; a pre-
existing macular pathology; chronic treatment with
corticosteroids; pregnancy; and/or systemic disease.
We compared pre- and postoperative values, and
achieved to attempted refractive outcomes. All eyes were
examined preoperatively, and at 1, 3, and 6 months after
surgery. Each examination included slit-lamp
assessment; measurement of uncorrected visual acuity
(UCVA), best spectacle-corrected visual acuity (BSCVA),
logarithm of the minimum angle of resolution of UCVA
(logMAR UCVA), and logMAR BSCVA; applanation
tonometry; manifest refraction (MR) assessment;
measurement of the spherical equivalent (SE); and
indirect ophthalmoscopy. Power vector analysis was
used to analyze the spherocylindrical refractive error
change.12 Refractive errors were converted to power
vectors suitable for display in a three-dimensional
dioptric space by using a Cartesian coordinate system
(M, J0, J45). Each power vector represented a spherical
lens of power M, a Jackson crossed cylinder of power J0
with axes at 90 and 180 degrees, and a Jackson crossed
cylinder of power J45 with axes at 45 and 135 degrees.
Surgically induced astigmatism was calculated by
using the polar value method.13 In the relevant equation,
the polar value KP(j) denotes the net refractive power
acting along the plane j. Thus, a positive KP(j)SIA value
indicates a surgically induced increase in power, whereas
a negative value reflects a surgically induced decrease in
the power of the meridian. We used KP(90)SIA values to
evaluate surgically induced astigmatism triggered by use
of different incision sites and sizes. A positive KP(90)SIA
value indicated a with-the-rule change and a negative
KP(90)SIA value an against-the-rule change, with net
flattening of the 90 degree corneal meridian.
Astigmatism induced by the surgical procedure was
calculated as the difference between the postoperative
and preoperative polar values. To obtain KP(90)SIA values
at 1-month postoperative follow-up visits, we subtracted
KP(90)Preop from KP(90)Postop1M. KP(90)Postop3M and
KP(90)Postop6M values were calculated in the same
manner.
The standardized format of Koch et al14 is used to
report refractive surgery results.
Surgical procedure
Toric ICL lens. A Visian toric ICL was implanted into
30 eyes. The toric ICL is a posterior chamber pIOL
designed to vault anteriorly to the crystalline lens, thus
minimally contacting the natural lens. The haptic design
of the toric ICL is identical to that of a spherical ICL in
terms of size, thickness, and configuration, and the lens
has a central convex/concave optical zone and a cylinder
located on an axis specific to each patient, for correction
of astigmatism. All lens power calculations were
performed by the STAAR Surgical Company, using the
astigmatic power calculations for IOLs derived by Sarver
and Sanders.15
Within 2 weeks prior to surgery, bilateral iridotomy
was performed by using a neodymium:yttrium–
aluminum–garnet (Nd:YAG) laser to prevent possible
postoperative pupillary block glaucoma. On the day of
surgery, each surgeon indicated the zero horizontal axis
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on a slit lamp with the patient sitting upright (to prevent
possible cyclotorsion in the supine position). The surgeon
used a Mendez ring to assess the extent of required
rotation from the horizontal during the operation. The
toric ICL was injected through a 3-mm-sized horizontal
temporal corneal incision, and the haptics were located
behind the iris by using a manipulator. Positioning of the
toric ICL in the centre of the pupillary zone was checked
before an intraocular miotic was used to decrease pupil
size. Any remaining viscoelastic material (Healon; AMO,
Santa Ana, CA, USA) was washed out of the anterior
chamber by using a balanced salt solution.
Toric Artisan IOL. A toric Artisan IOL was implanted
into 31 eyes. The toric Artisan is an iris-fixated anterior
chamber lens made of Perspex CQ-UV polymethyl
methacrylate, and filters ultraviolet light. Model-A, with
a 0-degree torus axis, is recommended for eyes in which
the preoperative cylinder axis lies between 0 and 45
degrees or 135 and 180 degrees. Model-B, with a
90-degree torus axis, is recommended for eyes in which
the preoperative cylinder axis lies between 45 and 135
degrees. Both models can be suitably enclavated. The
power and enclavation axis of the toric Artisan IOL were
calculated based on ACD, keratometric readings, and
subjective refraction error assessment, by using the Van
der Heijde formula.16
Within 2 weeks prior to surgery, bilateral iridotomy
was performed by using a Nd:YAG laser to prevent
possible postoperative papillary block glaucoma. Miotic
drops (pilocarpine; 1–2% v/v) were administered to
prepare the iris for lens enclavation, and a superior
sclerocorneal incision 6.1–6.3 mm in length and two
paracenteses were created for all eyes. The anterior
chamber was filled with viscoelastic material (Healon).
After delivery of the toric Artisan IOL into the anterior
chamber by using holding forceps, the lens was
positioned on the desired axis and next fixated to the
mid-peripheral iris stroma by using a disposable
enclavation needle. After correction of alignment, the
lens was enclavated onto the iris. The incision site was
closed by using three-bite interrupted 10-0 nylon sutures.
Within the first 2 postoperative months, the sutures were
removed at times dictated by the presence of residual
refraction and/or keratometric astigmatism.
Statistical methods
Changes between the two pIOL groups were compared
by using a mixed model of repeated measures. Paired
t-tests were employed to analyze within-group changes.
Intra-class correlation coefficients (ICCs) were calculated
after the 6-month follow-up to assess the difference
between attempted and achieved diopter values.
To compare gain or loss of BSCVA, Fischer’s exact test
was used. A P-value o0.05 was considered significant.
Results
Table 1a summarizes the preoperative baseline
characteristics of our patients. There were no significant
differences between the two toric pIOL groups in any of
preoperative logMAR UCVA, logMAR BSCVA, cylinder
power, or SE values. We observed significant
improvements in logMAR UCVA after surgery in both
groups, but toric ICL patients showed better
postoperative logMAR UCVA values at all follow-up
visits (Table 1b and Figure 1a).
SE improved in both groups (Table 1b and Figure 1c);
no significant between-group difference was evident at
any follow-up visit. The manifest cylinder power also
improved in both groups by 6 months postoperatively
(Table 1b and Figure 1b), but between-group differences
were apparent. The toric ICL group attained 0.88 D at
the 1-month follow-up, and this value decreased
continuously thereafter. However, the toric Artisan group
showed a definitive reduction in manifest cylinder power
only at 3 months. Therefore, a significant difference in
cylindrical power was evident only at the 1-month
follow-up (Table 1b and Figure 1b).
In terms of gain or loss of BSCVA, the toric Artisan
group showed a greater extent of loss of two or more
lines of BSCVA at the 1-month follow-up visit (13.4% of
toric Artisan patients; 4% of toric ICL patients; P¼ 0.013),
and loss of at least one line of BSCVA at all follow-up
visits. The toric ICL group showed a better gain of one or
more lines of BSCVA. During follow-up, the extent of
gain of one or more lines of BSCVA changed from 72 to
92% in the toric ICL group and from 26.7 to 66.7% in the
toric Artisan group. Improvement in gain of two or more
lines of BSCVA was better in the toric ICL group at the
1- and 3-month follow-up visits (12 vs 3.3% at 1 month;
12 vs 10.7% at 3 months; 12 vs 14.8% at 6 months). The
only statistically significant difference was noted at
1 month (P¼ 0.003).
Scattergrams (Figure 2) depict predictability at the
6-month follow-up visit. The ICC of SE was 0.97 for the
toric Artisan group and 0.98 for the toric ICL group. The
ICC of manifest cylinder power was 0.53 for the toric
Artisan group and 0.61 for the toric ICL group. These
differences were not significant.
However, in the toric Artisan group, the distribution of
postoperative manifest cylinder power was wider and
skewed more to larger values than was the case in the
toric ICL group (Figure 3). Most manifest cylinder power
values in toric ICL patients were between 1.50 and
0.25 D at the 1- and 3-month follow-up visits and
between 0.25 and 0 D at the 6-month follow-up visits.
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Most patients in the toric Artisan group had manifest
cylinder powers of more than 2.0 D at the 1-month
follow-up visit, but this distribution pattern had changed
by the 3-month follow-up. Most patients had manifest
cylinder powers between 1.0 and 0 D at the 6-month
follow-up.
For power vector analysis, we converted
spherocylindrical refractive errors into three
independent dioptric components, to allow changes in
refraction caused by surgery to be calculated by simple
vector subtraction. The vectors were expressed in a
Cartesian coordinate system (M, J0, J45):
M ¼ S þ C=2
J0 ¼ ðC=2Þ cosð2aÞ
J45 ¼ ðC=2Þ sinð2aÞ;
where S is the spherical diopter value, C the cylinder
diopter value, and a is an angle (in degrees).
Manifest refraction is presented by using the
conventional method (spherical diopter, and cylinder
diopter a). The converted cylinder values J0 and J45
reflect astigmatic components and were used to compare
changes in astigmatism. The astigmatic component of the
power vector was represented in a two-dimensional
vector coordinate system (J0, J45), to assess changes in
astigmatism. We calculated the magnitude of the
astigmatism vector of each eye (J0, J45) and compared
mean values between the two pIOL groups (Figure 4).
The groups showed a significant difference in astigmatism
at the 1-month follow-up visit. However, over time, each
astigmatism vector approached zero (0, 0) in all patients of
both groups. Point scattering began to close to zero after the
1-month follow-up visit in the toric ICL group and after the
3-month visit in the toric Artisan group.
Table 1 Patient demographics and clinical outcomes
Characteristic T-ICL T-Artisan P-value (CI)a
(a) Baseline demographic and clinical characteristics of the T-ICL and T-Artisan groups.
Number of eyes (OD/OS) 30 (16/14) 31 (13/18)
Mean age: years (range) 28.6 (21–38) 29.0 (21–46)
Gender
Male 13 8
Female 17 13
LogMAR UCVA 1.67±0.33 1.65±0.52 0.940 (0.231B0.272)
LogMAR BSCVA 0.02±0.05 0.03±0.06 0.732 (0.021B0.272)
Mean spherical equivalent (range) 9.80±2.49 (14.63 to 5.5) 10.04±3.48 (11.75 to 2.13) 0.212 (1.792B1.317)
Mean manifest cylinder power (range) 2.47±0.66 (3.5 to 1.75) 2.62±0.54 (4.25 to 2.0) 0.588 (0.462B0.154)
Pre-op. Post-op. 1 month Post-op. 3 months Post-op. 6 months
(b) Changes in visual acuity and refractive error in the T-ICL and T-Artisan groups.
LogMAR UCVA
T-ICL 1.67±0.33 0.02±0.11 0.04±0.09 0.04±0.08
T-Artisan 1.65±0.52 0.13±0.15 0.06±0.10 0.03±0.06
P-valuea 0.940 o0.001 0.026 0.021
LogMAR BSCVA
T-ICL 0.02±0.05 0.02±0.08 0.07±0.04 0.09±0.03
T-Artisan 0.03±0.06 0.03±0.08 0.03±0.06 0.04±0.06
P-valuea 0.732 0.112 0.136 0.277
SE
T-ICL 9.80±2.49 0.37±0.37 0.22±0.32 0.09±0.38
T-Artisan 10.04±3.48 1.00±0.62 0.75±0.62 0.65±0.50
P-valuea 0.212 0.20 0.266 0.245
Manifest cylinder power
T-ICL 2.47±0.66 0.88±0.38 0.74±0.36 0.44±0.44
T-Artisan 2.62±0.54 2.75±1.97 1.17±1.29 0.75±0.64
P-valuea 0.588 o0.001 0.162 0.330
Abbreviations: CI, 95% confidence interval; LogMAR BSCVA, logarithm of the minimum angle of resolution of best spectacle-corrected visual acuity;
LogMAR UCVA, logarithm of the minimum angle of resolution of uncorrected visual acuity; op., operation; T-Artisan, iris-fixated toric phakic intraocular
lens; T-ICL, Toric implantable collamer lens.
aMixed model allowing estimates of repeated measures.
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The KP(90)SIA values in the toric Artisan group were
3.60±3.10, 0.22±0.76, and 0.2±0.53 D at the three
follow-up visits (1, 3, and 6 months, respectively) and
0.18±0.23, 0.26±0.32, and 0.29±0.38 D in the toric ICL
group. Significant changes in KP(90)SIA value were
evident between every follow-up period in the toric
Artisan group (Po0.001 between 1 month and 3 months;
P¼ 0.03 between 3 and 6 months). However, no
significant difference in KP(90)SIA value was noted
between visits in the toric ICL group. The KP(90)SIA
Figure 1 Mean changes in logMAR UCVA, SE, and manifest cylinder power in patients receiving the Visian toric ICL and the Iris-
fixated toric pIOL (toric Artisan). The logMAR UCVA values improved in both groups, but the toric ICL group showed significantly
better logMAR UCVA values at 1 month, 3 months, and 6 months after implantation (a). The manifest cylinder power improved in
both groups, but a significant difference was evident between groups at the 1-month follow-up (b, Po0.001). The mean manifest
cylinder power was 0.88 D in the toric ICL group and 2.75 D in the toric Artisan group at the 1-month follow-up. SE values
improved in both groups, and no significant difference was evident between groups over the entire follow-up period (c). The vertical
bars indicate 95% confidence intervals (*Po0.05).
Figure 2 Scattergrams of attempted vs achieved correction at the 6-month follow-up (a, SE; b, manifest cylinder power). The ICC of
the SE was 0.98 in the toric ICL group and 0.97 in the toric Artisan group. The ICC of manifest cylinder power was 0.61 in the toric ICL
group and 0.53 in the toric Artisan group.
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values noted at 3 months postoperatively did
not significantly differ between the two groups
(P¼ 0.43).
The safety index is defined as the ratio of mean
postoperative BSCVA to mean preoperative BSCVA, and
the efficacy index is the ratio of mean postoperative
UCVA to mean preoperative BSCVA. The safety indices
in the toric ICL group were 1.186, 1.228, and 1.278 at the
three follow-up visits, and 1.003, 1.137, and 1.187 in the
toric Artisan group. The efficacy indices were 1.016,
1.163, and 1.155 in the toric ICL group, and 0.827, 0.938,
and 1.009 in the toric Artisan group. Both safety and
efficacy index values were somewhat higher at all
postoperative visits in the toric ICL group, but this was
not statistically significant.
No patient experienced any pIOL-related
complications, such as severe endothelial cell loss, a
cataractous change, rotation of the pIOL, elevation
of intraocular pressure, or inflammation, during
follow-up.
Discussion
Correction of astigmatism is a current challenge in
refractive ocular surgery. Laser surgery is limited in
terms of correction of high myopia and high
astigmatism,17,18 and is also associated with the
complications common to keratorefractive procedures
(corneal ectasia, regression, poor quality of dark vision),
likely caused by changes in corneal contours.19,20
Toric pIOL implantation is not associated with such
complications, and can correct high astigmatism
regardless of corneal thickness. Several studies have
found that the toric Artisan lens provides safe, effective,
and reliable correction of high myopia and
astigmatism.6,10,21 Alio´ et al7 previously described the
ability of the toric Artisan lens to correct astigmatism and
concluded that this approach offered a significant
advantage over corneal refractive surgery when a high
degree of astigmatism was present. A 6-month
multicentre clinical trial in Europe demonstrated that the
Artisan toric pIOL produced stable refractive effects, and
predictably and effectively reduced astigmatism.6
A US FDA study of the toric ICL reported that use of
this lens is a reliable, predictable, and effective option for
correction of moderate-to-high myopic astigmatism.11
Another study, based on the US FDA data, reported
similar visual and refractive outcomes, and
predictabilities, of toric ICLs implanted in Asian and
non-Asian populations.22 Schallhorn et al23 found that
Figure 3 Distribution of manifest cylinder power 1 month and 6 months after surgery in the two groups, and distribution of manifest
cylinder power in either toric pIOL implantation group after surgery.
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Figure 4 Distribution of the astigmatism vectors (J0, J45) of the toric Artisan and toric ICL groups using a two-dimensional vector coordinate
system. The point scatter gradually approached zero, over time, in both groups. The astigmatism distribution in the toric Artisan group changed
significantly between 1 month and 3 months after surgery (Po0.001); at 3 months after surgery, all points were close to the origin (0, 0).
However, a significant difference was evident only between preoperative values and 1-month follow-up data in the toric ICL group (Po0.001).
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toric ICLs were better than was photorefractive
keratectomy in terms of stability, predictability, safety,
and efficacy.
Although several previous reports have compared
visual outcomes between patients receiving ICL or
Artisan implantation, and keratorefractive surgeries, the
present study is the first to compare the toric ICL and
toric Artisan lenses. We found no significant between-
group difference in logMAR BSCVA at 1, 3, or 6 months
after surgery. However, toric ICL patients experienced
better outcomes in terms of logMAR UCVA at all
postoperative follow-up visits. We are of the view that
residual astigmatism might influence the statistically
significant differences observed in logMAR UCVA. In
other words, it is possible that a between-lens difference
in astigmatism correction ability affected the logMAR
UCVA values.
The toric ICL lens was associated with better outcomes
at 1-month follow-up visits when cylinder power and
vector astigmatism analysis were assessed (Figures 1c
and 4). By contrast, the manifest cylinder power and
astigmatism vector analysis of toric Artisan data 1 month
after operation indicated an increase in the level of
astigmatism, which we consider to be attributable to the
incision length. Distribution analysis of manifest cylinder
power also showed that the toric ICL lens afforded
superior correction. After the 3-month follow-up visits,
manifest cylinder power and astigmatism values stabilized.
We used ICC to evaluate the match between attempted
and achieved correction at the 6-month follow-up visits.
The two groups showed similar ICC values in terms of
SE predictability, indicating that the SE correction ability
of the two lenses was similar. Although the ICCs for
predictability of cylinder power were low (0.53 in the
toric Artisan group and 0.61 in the toric ICL group), the
toric ICL group experienced superior outcomes in terms
of predictability of cylinder power at the 6-month follow-
up visits. The between-group differences in efficacy and
safety indices were not statistically significant.
Vision stability after pIOL insertion is important.
Despite the BSCVA decrease in both groups 1 month
after pIOL insertion, almost all patients showed full
recovery of BSCVA (one eye was an exception) after
6 months. As the pattern of BSCVA change indicates not
only the extent of recovery after operation, but also the
durability of the procedure per se, our results indicate
that toric ICL patients experienced a faster recovery time
and a greater operative stability than did the toric Artisan
patients. Six months after pIOL insertion, only one eye in
the toric Artisan group showed a BSCVA decrease of one
line. The preoperative BSCVA of 20/16 became 20/20,
which was not a negative outcome in terms of
postoperative visual acuity, despite the fact that a
recovery time of 6 months was insufficient.
Furthermore, no patient in either group had a BSCVA
less than 20/20 at 6 months after operation. This shows
that the two groups experienced similar levels of vision
stability 6 months after lens insertion.
In comparing the two surgical methods it is necessary
to consider incision location and size. The toric Artisan
and toric ICL patients differed in terms of location and
size; these factors can influence the extent of surgically
induced astigmatism. In the present study, the toric
Artisan patients showed astigmatism of 3.60±3.10 D
KP(90)SIA at 1 month postoperatively. This value was
sufficiently large to affect postoperative astigmatism and
to decrease visual quality. Between-group differences in
manifest cylinder power and the extent of astigmatism
might also be affected by the nature of the surgical
incision. Such factors can confuse the interpretation of
surgical results. However, the most remarkable outcome
was the change in the pattern of KP (90)SIA values from
3 months postoperatively. As mentioned above, a
KP(90)SIA value measures the net refractive power acting
along the axis of a plane at 90 degrees. Although
KP(90)SIA was positive at all follow-up visits in patients
in the toric ICL group, the variation in KP(90)SIA levels
was not large in comparison with those of the toric
Artisan group. This indicates that astigmatism induced
in toric ICL patients was stable. When the two groups
were compared, the KP(90)Postop3M values showed no
statistically significant difference, whereas the
KP(90)Postop6M value in the toric Artisan group was
negative, indicating a flattening effect of the 90 degree
axis. All patients in the toric Artisan group had with-the-
rule astigmatism before surgery (average steep axis:
90.86±9.82 degrees in the toric Artisan group;
92.37±7.81 degrees in the toric ICL group). Therefore,
the flattening effect of surgically induced astigmatism at
6 months of follow-up positively influenced the surgical
results in the toric Artisan group. Obviously, longer
postoperative follow-up is necessary to accurately
evaluate the stability of surgically induced astigmatism.
However, one can exclude the effect of incision location
and size to some extent by calculating the level of
surgically induced astigmatism. Such estimates revealed
that the effect of incision location on induced
astigmatism was not large; this was apparent when
astigmatism levels in the two pIOL groups were
compared 3 months after operation.
Based on our present results, we conclude that the two
toric pIOLs are of similar effectiveness when correction
of refractive error and astigmatism are assessed after
3 months. However, use of the toric ICL was associated
with rapid clinical improvement and was superior in
terms of predictability and safety. Although surgically
induced astigmatism caused by incision was more
effective in the toric Artisan group in terms of
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astigmatism correction, the better results in terms of
cylinder power, as revealed by vector analysis, of the
toric ICL group, indicate that the toric ICL better corrects
astigmatism. Not only the difference in the extent of
astigmatism correction 1 month after operation, but also
the superior ability to correct astigmatism and the fast
recovery, will greatly influence patient decision-making
towards use of a toric ICL.
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Summary
What was known before
K It is well known that toric Artisan and toric ICL are
effective in correction of myopia with astigmatism.
K No previous studies have compared the efficacy and
safety of two toric pIOLs (toric Artisan and toric ICL)
in the correction of myopia with astigmatism.
What this study adds
K Compared the efficacy and safety of two toric pIOLs (toric
Artisan and toric ICL) in the correction of myopia with
astigmatism.
Visual outcomes after Visian toric ICL and toric Artisan implantation
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